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If we could avoid the side effects associated with global sympathetic activation, activating brown adipose
tissue to increase thermogenesiswouldbeasafeway to loseweight. Thediscoveryof adrenergic-independent
brown fat activators opens the prospect of developing this alternative way to efficiently and safely induce
negative energy balance.Introduction: Identifying Alternative Activators of Brown
Adipose Tissue to Safely Lose Weight
A careful historical analysis of antiobesity drugs (e.g., Fenfluor-
amine/Phenteramine, sibutramine, or Ma Huang/ephedra)
showed that those drugs that exhibited efficacy were character-
ized by a nondiscriminate increase in the activity of the sympa-
thetic nervous system (SNS). Whereas nonselective activation
of the SNS succeeded in creating negative energy balance
weight loss, the drugs’ associated cardiovascular side effects
prevented their use in clinical settings (Yen and Ewald, 2012).
Thus, a lesson learned from this failure is that for SNS-based
weight loss strategies to be successful, they will need to selec-
tively activate thermogenesis and avoid collateral cardiovascular
side effects.
The regulation of the SNS tone provides a complex homeo-
static mechanism able to specifically coordinate the function
and crosstalk of the organs involved in energy balance. Whereas
the adaptive thermogenic response to cold and high-fat diet in-
creases the SNS outflow to brown adipose tissue (BAT), the
different lipolytic requirements of these two conditions are
appropriately met by the increase or decrease of the sympa-
thetic outflow to selected white adipose tissue (WAT) depots
(Brito et al., 2008). This organ selectivity of the SNS is also
observed during caloric restriction, which is characterized by a
decrease in the sympathetic outflow to BAT resulting in reduced
energy expenditure, and simultaneous increase in SNS outflow
to specific WAT depots to facilitate lipid mobilization. In obese
patients, regulation of the SNS outflow seems to be more wide-
spread and more complex than in nonobese subjects, preferen-
tially affecting heart, kidneys, muscle, and vascular wall, which
primes the development of cardiovascular complications. The
key points are that regulation of the SNS allows specific
responses to specific physiological conditions, and that the
adaptive SNS response to cold promotes thermogenesis by
preferentially targeting BAT and is devoid of undesirable cardio-
vascular effects. Substantial evidence has accumulated to
conclude that BAT activation leads to increased thermogenesis
and can prevent or reverse obesity and diabetes in multiple
experimental models. Moreover, BAT is being recognized as a
sink in which circulating lipids and glucose are actively oxidized,638 Cell Metabolism 17, May 7, 2013 ª2013 Elsevier Inc.thus potentially contributing to the prevention of hyperlipidemia
and hyperglycemia (Cannon and Nedergaard, 2004).
Thus, therapeutic approaches optimizing the thermogenic
function of BAT without side effects derived from SNS activation
may include (1) selective stimulation of SNS to BAT, (2) increased
sensitivity of BAT to SNS, or (3) identification of more specific
ways of activating BAT beyond SNS activation using recently
identified activators of BAT. These activators may act either
independently of or in association with the SNS pathways. These
three strategies might bypass the negative cardiovascular
outcomes of nontargeted, pharmacological SNS activation while
offering novel ways of promoting energy expenditure, and
ameliorating obesity and associated metabolic derangements.
This brief review provides an integrated view of these novel
stimulators of BAT activity.
Biological Processes that Optimize BAT-Mediated
Thermogenic Activity
The capacity of the organism to generate heat and dissipate en-
ergy through BAT depends on adaptive mechanisms designed
to match thermogenic requirements. From rodent model studies
we have learned that the development of optimal BAT thermo-
genic capacity for adaptive energy expenditure involves two pro-
cesses: (1) the so-called ‘‘browning’’ of WAT, defined as the
appearance after thermogenic stimuli of functional brown adipo-
cytes (also named brite or beige) in WAT depot; and (2) the
‘‘recruitment’’ of existing BAT depots, involving hypertrophy
and hyperplasia of canonical brown adipocytes, an issue that
has been somewhat overlooked recently owing to the current
enthusiasm for the WAT ‘‘browning’’ process. This focus is, in
part, justified by recent observations indicating that active BAT
in adult humans is predominantly derived from the ‘‘browning’’
process, highlighting the potential relevance of beige/brite cells
in determining the amount of active BAT in humans. Moreover,
rodent studies indicate that the presence and capacity to induce
brite/beige adipocytes in WAT is strongly influenced by genetic
background.
Although both processes, browning and canonical BAT
development, are induced by the SNS in response to thermo-
genic stimuli, they are regulated through distinct cell-specific
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agents might differentially influence them and potentially offer
specific therapeutic advantages. Their potential use in humans
justifies the current rush to identify novel molecules and path-
ways that control BAT activity. These novel BAT activators
seem to exert their effects at different signaling levels and
through mechanisms that differ with respect to the canonical
processes involved in BAT activation. Collectively, these new
functional modulators add new layers of complexity in the
endocrine control of BAT-mediated energy expenditure and
also provide potential therapeutic opportunities to manipulate
this system beyond the control of sympathetic tone. These newly
identified molecules and their ability to control endocrine and/or
paracrine-autocrine signaling pathways that activate existing
BAT or induce ‘‘browning’’ (or both), and the extent to which
they act in concert with or independently of the classic
SNS-dependent pathways of BAT activation, are the focus of
this review.
Control of BAT Thermogenic Activation by Vitamin A
Derivatives
The idea of nonadrenergic pathways stimulating BAT is not
strictly new, as it has been known since the 1990s that retinoids
(vitamin A derivatives) are powerful activators of BAT recruitment
and transcription of the uncoupling protein-1 (UCP1) gene. Ret-
inoic acid is a direct and strong nonadrenergic inducer of UCP1
gene transcription (Alvarez et al., 1995) that, when administered
chronically to mice, induces WAT remodeling reminiscent of the
‘‘browning’’ effect (Mercader et al., 2006). Because most avail-
able retinoic acid-related data have been obtained from in vitro
studies using brown adipocyte cellular models, or pharmacolog-
ical treatments in animal models, there has been some concern
about the therapeutic relevance and physiological meaning of
this modulatory effect of vitamin A derivatives on BAT activation.
However, a recent study by Kiefer et al. (2012) employing exper-
imental loss of function of retinaldehyde dehydrogenase, the
enzyme that converts retinal to retinoic acid, demonstrated
that this system is fully operational and relevant in vivo, confirm-
ing a central role for retinal in BAT activation. Of note, the
traditionally recognized intracellular mediator of the vitamin A
effect is retinoic acid, the product of vitamin A (retinol) oxidation
via the intermediate retinal. The surprising finding that retinal is a
major inducer of BAT activity in vivo highlights the relevance of
the intracellular metabolism of vitamin A derivatives as biologi-
cally activemodulators of BAT thermogenesis. The physiological
relevance for this sensitivity of BAT thermogenic activity to
the vitamin A derivatives is unclear. Moreover, the prospect of
using vitamin A derivatives to promote BAT thermogenesis is
dimmed by the strict intracellular control over the generation of
the biologically active molecules from vitamin A (retinal and,
possibly, retinoic acid) and their pharmacological toxicity in
human therapies.
The Thyroid System: Old and New Roles Controlling
BAT Activation
In addition to the SNS, the thyroid system is the other ‘‘usual sus-
pect’’ to contribute to BAT thermogenesis. The presence in BAT,
but not in WAT, of type II thyroxine 50-deiodinase, an enzyme
controlled by norepinephrine, capable of generating triiodothy-ronine (T3) from thyroxine (T4), highlights the integration of the
SNS and thyroid systems. Intracellular T3 activates its thermo-
genic program in brown adipocytes, most notably by inducing
the transcription of the UCP1 gene. However, recent data also
indicate that the role of thyroid hormones in BAT thermogenesis
may be more complex than initially anticipated. First, 50-deiodi-
nase in BAT appears to be regulated by bile acids coming from
the liver (see below). Second, the thyroid effects on the hypothal-
amus (Lo´pez et al., 2010) might be an important determinant of
peripheral BAT activation through the induction of AMP-kinase
in the hypothalamus, leading to enhanced activation of the
SNS and ultimately to the induction of BAT thermogenesis.
These findings have revealed a direct connection between the
thyroid and the canonical SNS-signaling pathway in BAT, and
highlight the fact that integrated modulation of central and
peripheral thyroid system is required for the physiological regu-
lation of BAT-mediated thermogenic activation, both through
intracellular mechanisms and via activation of a hypothalamic-
mediated loop.
The Liver Connection: Bile Acids, FGF21, and More
One of the first strong indications that hepatic activity might be
directly involved in the control of BAT activity came from a report
showing that bile acids (Watanabe et al., 2006) promote BAT
thermogenesis via interaction with the thyroid system. It was re-
ported that bile acids secreted after meals induced BAT thermo-
genic activity via the induction of 50-deiodinase. This effect
required bile acids to interact with (and thus activate) the G pro-
tein-coupled bile acid receptor, TGR5, which is present in high
levels in BAT. Once activated, TGR5 increases intracellular
cAMP levels, leading to an increase in 50-deiodinase and local
generation of T3. Increased intracellular T3 levels induce UCP1
gene expression, as noted above. In addition, recent data also
indicate that bile acids may indirectly induce BAT activity via
glucagon-like peptide-1 (GLP1). Using a combination of elegant
pharmacological and genetic gain- and loss-of-function ap-
proaches, Schoonjans et al. showed that bile acid stimulation
of TGR5 signaling induces the release of the GLP-1 by the intes-
tine (Thomas et al., 2009). Moreover, activation of GLP-1 recep-
tor signaling in the central nervous system (CNS) was found to
contribute to BAT thermogenic activation (Lockie et al., 2012),
closing a loop integrating hepato-gastrointestinal and CNS
signaling that may contribute to diet-induced BAT thermogenic
function.
Another important hepatic factor, recently recognized to play a
role in a liver-to-BAT regulatory loop, is fibroblast growth factor-
21 (FGF21), a member of the endocrine subfamily of FGFs.
FGF21 elicits antidiabetic and weight-loss effects when adminis-
tered to rodent models of obesity and type 2 diabetes. FGF21
induces the thermogenic program in brown adipocytes by inter-
acting with FGF receptor/b-Klotho complexes at the cell surface
and, subsequently, inducing mitochondrial uncoupled respira-
tion and glucose oxidation (Hondares et al., 2010). FGF21
released by the liver directly activates heat production by BAT
in neonates. In adults, FGF21 promotes the ‘‘browning’’ of
WAT depots and also induces, to some extent, BAT activation
(Fisher et al., 2012). The recognition that BAT is both a target
for FGF21 as well as a site for FGF21 production highlights a
highly integrated response that involves a direct autocrine effectCell Metabolism 17, May 7, 2013 ª2013 Elsevier Inc. 639
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BAT by FGF21 that originates in the liver. With respect to the
central effects of FGF21, or the potential interaction between
FGF21 and SNS, this has not been extensively studied. Thus,
current evidence suggests that FGF21 is an autonomous, direct
activator of BAT.
Muscle, Exercise, and the Control of BAT Activity: Irisin
and Beyond
Exercise increases BAT activity; however, it is unclear whether
this effect is mediated by activating existing BAT depots or
through ‘‘browning’’ of WAT. Although no definitive cause-and-
effect data are available, it is tempting to speculate that part of
the improvement in metabolic health ascribed to exercise could,
in fact, be mediated by the thermogenic effects derived from
BAT activation. It is known that the skeletal muscle releases mul-
tiple signaling molecules (myokines), but there is no conclusive
evidence indicating that the major myokines, such as inter-
leukin-6, have relevant effects on BAT activation. The recent dis-
covery of irisin (Bostro¨m et al., 2012) may change this. Irisin was
identified through analysis of proteins released by muscle
engineered to overexpression of PGC-1a (peroxisome prolifera-
tor-activated receptor-g, coactivator-1a), a transcriptional coac-
tivator that coordinates some of the metabolic adaptations
induced by exercise in muscle. Irisin is generated by proteolytic
cleavage of the FNDC5 membrane protein, and, although still
controversial, exercise in rodents and humans appears to
enhance irisin levels in muscle. Notably, irisin has been
described as a powerful promoter of WAT ‘‘browning,’’ protect-
ing against obesity in rodents. These findings suggest irisin rep-
resents a muscle-to-BAT (or BAT-in-WAT) connection by which
exercising muscle positively influences systemic metabolism.
The potential therapeutic applications of irisin in the promotion
of energy expenditure are only beginning to be explored, but
theymay be especially relevant in conditions in whichmuscle ex-
ercise, the physiological supplier of endogenous irisin, is not
possible. Recent findings indicating high levels of FGF21 in
blood in response to mitochondrial respiratory alterations in
muscle stress the possibility of further muscle-to-BAT communi-
cation involving also FGF21 (Turnbull, 2011).
A Heart-to-BAT Connection
A recent report by Bordicchia et al. (2012) has shown that the
heart also has an unexpected ‘‘say’’ in the activation of BAT.
Natriuretic peptides (NPs) are hormones produced mainly in
the heart. Both, atrial NP (ANP) and especially ventricular NP
(BNP), enhance BAT thermogenic recruitment as well as the
‘‘browning’’ of WAT. The thermogenic action of NPs is additive
to the effects of adrenergic activation. ANP and BNP interact
with NP receptors (NPRs) on the brown adipocyte surface to
activate cGMP-dependent protein kinase (PKG). This signaling
pathway ultimately converges on the standard BAT thermogenic
signaling program involving the induction of p38 MAP-kinase
activity. The activation of p38 MAP kinase is known to induce
the thermogenic gene expression program in BAT, including
the expression of UCP1, PGC-1a, and the complete set of genes
encoding enzymes involved in fatty acid catabolism and
mitochondrial oxidation. Of note, mice lacking NP clearance re-
ceptor, a negative regulator of NP activity, show enhanced ther-640 Cell Metabolism 17, May 7, 2013 ª2013 Elsevier Inc.mogenic gene expression in WAT and BAT, ‘‘browning’’ of WAT
depots, and overall reduction of body fat deposition. Moreover,
treatment of mice with BNP increases energy expenditure and
the expression of thermogenic genes in BAT and WAT. The
crosstalk between heart and BAT may not be restricted to the
NPs. Cardiotrophin-1 (Moreno-Aliaga et al., 2011) has recently
been identified as a heart/muscle-derived protein able to induce
WAT ‘‘browning,’’ enhanced energy expenditure, and protection
against obesity in animal models. Cardiotrophin-1 is a member
of the gp130 family of cytokines that originates in the heart and
muscle. It is unclear whether other members of the gp130 family,
such as ciliary neurotrophic factor and interleukin-6, may also
play a role in the control of BAT activity; however, the results
obtained from cardiotrophin-1 highlight that cytokine signaling
may be directly involved in the control of BAT.
Thus, proteins released from the heart seem to be able to
regulate BAT activity. However, the physiological relevance of
this effect remains to be proven. Crosstalk linking BAT with the
heart is conceivable, as the activation of BAT by a thermogenic
stimulus (e.g., cold environment) requires increased cardiac
output. Similarly, the adaptive release of cardiac factors to
induce BAT thermogenic as a strategy to maintain a temperature
that optimizes the heart function cannot be discarded.
TheUnanticipated Role ofMacrophages in the Induction
of BAT Activity
One of the more surprising findings in the nascent field of novel
BAT activators is the observation by Nguyen et al. that alterna-
tively activated macrophages control BAT thermogenesis via
local release of catecholamines (Nguyen et al., 2011). Following
on the heels of studies showing the role of local WAT inflamma-
tion on obesity-associated metabolic derangements, an exten-
sive literature is emerging investigating the role of macrophages,
inflammation, and inflammation-related signaling pathways in
WAT pathophysiology. To date, the role of immune and inflam-
matory cells in BAT has been mostly neglected. One of the novel
findings of Nguyen et al. was that cold-induced thermogenic
activation promoted the alternative activation of macrophages
within BAT and that this process was an essential component
of the thermogenic response in BAT. Using several models of
experimental disruption of the alternative, interleukin-4/inter-
leukin-13-mediated pathway of macrophage activation, these
authors demonstrated that this process is required for appro-
priate cold-induced activation of thermogenic pathways in BAT
and also in the ‘‘browning’’ process that takes place in WAT.
These alternatively activated macrophages produce norepi-
nephrine, which seems to be required for BAT thermogenic
activation. If confirmed, this indicates that the hematopoietic
system constitutes a parallel circuit controlling BAT thermogen-
esis. These findings open a new avenue for investigating immune
cell-BAT relationships. Further research would be needed to
determine whether deregulation of this pathway contributes to
impairment of BAT or ‘‘brown-like’’ activity in adipose depots
in obesity-prone individuals.
Hypothalamic Control of BAT Thermogenesis,
an Integrated System
The CNS may be too complex to successfully devise selective
therapeutic strategies that specifically target thermogenesis or
Figure 1. The New BAT Activators and Their Mechanisms of Action
Norepinephrine released from the SNS endings after central activation in response to thermogenic stimuli is known to activate BAT via protein kinase A activation,
subsequent activation of p38 MAP kinase and thyroxine 50-dediodinase, and ultimate induction of the gene program of thermogenic activation. Alternatively
activated macrophages contribute to the production of norepinephrine eliciting this response. The liver contributes to BAT activation via the production of bile
acids, which interact with TGR5 receptors and activate 50-dediodinase and FGF21, a hormonal factor capable of directly activating brown adipocytes through the
interaction with FGF receptor/b-Klotho (KLB) complex in the cell surface. BMP8b is produced byBAT and, in an autocrinemanner, sensitizes the brown adipocyte
to the action of norepinephrine. Natriuretic peptides (NPs), originating mainly in the heart, induce BAT thermogenic activation through interaction with NP re-
ceptors (NPRs), activation of PKG, and subsequent activation of p38 MAP kinase. Irisin is a new myokine released by skeletal muscle, which induces BAT
activation, mainly via the promotion of the ‘‘browning’’ of WAT depots. Most of these novel activators promote BAT recruitment, the ‘‘browning’’ of WAT, or both
phenomena to a distinct extent.
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targeting the CNS failed to selectively target energy balance
mechanisms, together with the disturbing evidence that drugs
used to treat personality/mood disorders have major effects on
energy balance, certainly does not help to grow confidence in
targeting the CNS. However, the rediscovery of the BAT in
humans, and the evidence that central and BAT/peripheral
mechanisms controlling energy dissipation may share common
molecular mechanisms, has reactivated the interest for its regu-
latory mechanisms in the CNS. Moreover, even if central mech-
anisms do not provide viable therapeutic targets, knowledge of
them is important if we are to successfully target peripheral
mechanisms.
One recently recognized thermogenic activator that acts in
both CNS and periphery is bone morphogenetic protein-8b
(BMP8b) (Whittle et al., 2012). BMP8b acts directly on BAT,
sensitizing it to SNS stimulation; at the same time, it also
acts within discrete nuclei of the hypothalamus to modulate
the sympathetic outflow and activation of BAT. Furthermore,
the hypothalamic effect of BMP8b seems to selectively acti-
vate the SNS outflow toward BAT while sparing SNS flow to
the kidney. This suggests it is possible to selectively control
the SNS outflow to specific organs, which has obvious thera-
peutic implications. Thermogenic regulatory mechanisms
acting in both the hypothalamic and BAT are not uncommon.For example, orexins are important regulators of thermogene-
sis that elicit a double effect, on one hand controlling SNS
outflow from the CNS and on the other as direct promoters
of BAT (Sellayah et al., 2011) differentiation. Of interest, the tro-
phic effect of orexin on BAT has some similarities with BMP8b
and is mediated via bone morphogenetic protein receptor-1a
(BMPR1A)-dependent Smad1/5 signaling (Zhang et al., 2010).
Thus, an important point is that antiobesity strategies focused
on BAT-mediated energy expenditure will need to consider
counterregulatory homeostatic loops involving the CNS, BAT,
and probably other metabolically relevant tissues, even if the
main activator of BAT used is independent of adrenergic
receptor.
Ion Channels, New Players in the Control of Brown
Adipocyte Activation
The transient receptor potential melastin 8 (TRPM8) channel is a
cold-sensing cation channel present in sensing neurons that has
a role in detecting environmental temperature. Ma et al. (2012)
found that TRPM8 is expressed in BAT, and treatment with
TRPM8 agonists (e.g., menthol) induces BAT activity, promotes
energy expenditure, and protects against obesity in rodents.
Another ion channel, transient receptor potential vanilloid-4
(TRPV4), is a negative regulator of the ‘‘browning’’ process in
WAT, and pharmacological inhibition of TRPV4 leads to anCell Metabolism 17, May 7, 2013 ª2013 Elsevier Inc. 641
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et al., 2012). There is evidence for cell-autonomous effects of
these two ion channels on brown and brite/beige adipocytes,
respectively, but additional indirect effects mediated bymodula-
tion of SNS activity cannot be excluded. Although the identity of
the corresponding physiological ligands or regulators is un-
known, the aforementioned ion channels should be considered
as potential new candidates for pharmacological promotion of
BAT-mediated energy expenditure.Conclusions
In summary, BAT-induced thermogenesis is potentially a useful
antiobesity/antidiabetic strategy. However, in order for this to
become viable, given the scarcity of BAT in humans, it is essen-
tial to optimize the development and activation of BAT. Physio-
logically, the development and activation of BAT involve adren-
ergic stimulation mediated through the SNS. However, this
causes problems, as it is difficult to specifically target SNS acti-
vation of BAT. Potential approaches to solve this problem
include targeting the SNS at a central level; however, this pre-
sents huge challenges, given the complexity and promiscuity of
the neuronal networks. An alternative is to increase the sensi-
tivity of BAT to adrenergic stimulation, which in our opinion
may be more amenable, as shown by BMP8b. Finally, a more
pragmatic approach is to take advantage of the availability of
the new BAT activators beyond the SNS. However, their rele-
vance and therapeutic potential have yet to be defined.
These novel molecules promote BAT recruitment, the ‘‘brown-
ing’’ of WAT, or both, as summarized in Figure 1. It remains to be
elucidated which of these processes are predominantly affected
by each molecule, at which level their signaling pathways
influence the differentiation and activation of BAT, and whether
their effects are additive, synergistic, competitive, or comple-
mentary. Many of the signals originated in the periphery seem
to act independently of the SNS, but there are also examples
in which these signals are additive or complementary to central
or peripheral actions that sensitize BAT to SNS activity. This level
of complexity reflects the high degree of integration and redun-
dancy required to ensure tight metabolic regulation. This
efficiency is essential tomaintain stable body temperature. How-
ever, this efficiency also becomes a big disadvantage when
developing therapeutic strategies aiming to reset energy
balance. The new knowledge about signals that induce SNS-
independent BAT recruitment and/or activity may allow comple-
mentary, multistranded approaches to therapies that activate
BAT while preventing counterregulatory homeostatic loops that
compromise therapeutic success. This by itself justifies the
exploration of novel, nonadrenergic mechanisms targeting
energy expenditure to develop a new generation of safer anti-
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